APO Research
Talk to an analyst

APO RESEARCH · REPORT

Lipid Nanoparticle (LNP) CDMO Service

Compare research editions
View pricing & licenses

Selected research

Industry Research

Lipid Nanoparticle (LNP) CDMO Service Industry Research Report 2026

15 January 2026137 pages

Choose your research edition.

Industry ResearchLipid Nanoparticle (LNP) CDMO Service Industry Research Report 2026137 pages · $2,950 USDIndustry Growth & TrendsGlobal Lipid Nanoparticle (LNP) CDMO Service Industry Growth and Trends Forecast to 2032122 pages · $3,450 USDMarket StructureGlobal Lipid Nanoparticle (LNP) CDMO Service Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032197 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Lipid Nanoparticle (LNP) CDMO Service Market Outlook and Growth Opportunities 2026210 pages · $4,250 USDMarket Analysis & ForecastGlobal Lipid Nanoparticle (LNP) CDMO Service Market Analysis and Forecast 2026-2032213 pages · $4,950 USD

Market perspective

The global Lipid Nanoparticle (LNP) CDMO Service market was valued at US$ million in 2025 and is projected to reach US$ million by 2032, implying a CAGR of % over 2026–2032.

North America: the Lipid Nanoparticle (LNP) CDMO Service market is projected to increase from US$ million in 2026 to US$ million by 2032, reflecting a CAGR of % over 2026–2032. Europe: the Lipid Nanoparticle (LNP) CDMO Service market is projected to rise from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026–2032. Asia Pacific: the Lipid Nanoparticle (LNP) CDMO Service market is expected to grow from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026–2032. Leading global service providers of Lipid Nanoparticle (LNP) CDMO Service include Evonik, Helix Biotech, FUJIFILM Holdings, Merck, Ascendia Pharmaceuticals, Catalent, Polymun Scientific, Genevant Sciences and Cytiva, among others; in 2025, the top three vendors together accounted for approximately % of global revenue.

Report Scope

Read the full market overview

This report quantifies the global Lipid Nanoparticle (LNP) CDMO Service market in terms of revenue (US$ million) and, where applicable, service volume (k units), using 2024 as the base year and providing annual historical and forecast data for 2021–2032.

It standardizes definitions of service Types and end-use Applications, harmonizes provider attribution, and delivers comparable time series by company, Type, Application, and region or country, including indicative price bands (US$/k units) and concentration ratios (CR5/CR10). Outputs are intended to support service design, budgeting, capacity planning, and benchmarking for providers, platforms, channel partners, and investors; the report also reviews technology shifts and notable service innovations relevant to Lipid Nanoparticle (LNP) CDMO Service.

Key Companies & Market Share Insights

This section profiles leading service providers with 2021–2025 results and a 2026–2032 outlook—covering revenue, market share, price bands, service portfolio and client mix, regional and channel mix, and key developments (M&A, network expansion, certifications). It also provides global revenue, average price, and—where applicable—volume metrics by provider, and calculates CR5/CR10 and rank changes to support comparative benchmarking.

Lipid Nanoparticle (LNP) CDMO Service Market by Company

Evonik

Helix Biotech

FUJIFILM Holdings

Merck

Ascendia Pharmaceuticals

Catalent

Polymun Scientific

Genevant Sciences

Cytiva

Croda International

Nippon Fine Chemical

Patheon

Biomay

Pace Analytical

CordenPharma

Vernal Biosciences

Lonza

Acuitas Therapeutics

Creative Biolabs

WuXi STA

GenScript

MicroNano Biologics

Lipid Nanoparticle (LNP) CDMO Service Segment by Type

Formulation Development

cGMP Manufacturing

Others

Lipid Nanoparticle (LNP) CDMO Service Segment by Application

Vaccine Development

Gene Therapy

Drug Delivery

Others

Lipid Nanoparticle (LNP) CDMO Service Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Spain

Russia

Netherlands

Nordic Countries

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Saudi Arabia

Israel

United Arab Emirates

Turkey

Iran

Egypt

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Lipid Nanoparticle (LNP) CDMO Service market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Lipid Nanoparticle (LNP) CDMO Service and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market

5. This report helps stakeholders to gain insights into which regions to target globally

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Lipid Nanoparticle (LNP) CDMO Service.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Research objectives, research methods, data sources, data cross-validation;

Chapter 2: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 3: Provides the analysis of various market segments product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 4: Provides the analysis of various market segments application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 5: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.

Chapter 6: Detailed analysis of Lipid Nanoparticle (LNP) CDMO Service companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 7, 8, 9, 10, 11: North America, Europe, Asia Pacific, South America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.

Chapter 12: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including revenue, gross margin, product introduction, recent development, etc.

Chapter 13: The main points and conclusions of the report.

More report detail

Tables and figures
List of Tables Table 1. Secondary Sources Table 2. Primary Sources Table 3. Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 4. Market Value Comparison by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 5. Global Lipid Nanoparticle (LNP) CDMO Service Market Size by Type (2021-2026) & (US$ Million) Table 6. Global Lipid Nanoparticle (LNP) CDMO Service Revenue Market Share by Type (2021-2026) Table 7. Global Lipid Nanoparticle (LNP) CDMO Service Forecasted Market Size by Type (2027-2032) & (US$ Million) Table 8. Global Lipid Nanoparticle (LNP) CDMO Service Revenue Market Share by Type (2027-2032) Table 9. Global Lipid Nanoparticle (LNP) CDMO Service Market Size by Application (2021-2026) & (US$ Million) Table 10. Global Lipid Nanoparticle (LNP) CDMO Service Revenue Market Share by Application (2021-2026) Table 11. Global Lipid Nanoparticle (LNP) CDMO Service Forecasted Market Size by Application (2027-2032) & (US$ Million) Table 12. Global Lipid Nanoparticle (LNP) CDMO Service Revenue Market Share by Application (2027-2032) Table 13. Global Lipid Nanoparticle (LNP) CDMO Service Market Size by Region (US$ Million): 2021 VS 2025 VS 2032 Table 14. Global Lipid Nanoparticle (LNP) CDMO Service Market Size by Region (2021-2026) & (US$ Million) Table 15. Global Lipid Nanoparticle (LNP) CDMO Service Market Share by Region (2021-2026) Table 16. Global Lipid Nanoparticle (LNP) CDMO Service Forecasted Market Size by Region (2027-2032) & (US$ Million) Table 17. Global Lipid Nanoparticle (LNP) CDMO Service Market Share by Region (2027-2032) Table 18. Lipid Nanoparticle (LNP) CDMO Service Industry Trends Table 19. Lipid Nanoparticle (LNP) CDMO Service Industry Drivers Table 20. Lipid Nanoparticle (LNP) CDMO Service Industry Opportunities and Challenges Table 21. Lipid Nanoparticle (LNP) CDMO Service Market Restraints Table 22. Global Top Lipid Nanoparticle (LNP) CDMO Service Players by Revenue (US$ Million) & (2021-2026) Table 23. Global Lipid Nanoparticle (LNP) CDMO Service Revenue Market Share by Players (2021-2026) Table 24. Global Lipid Nanoparticle (LNP) CDMO Service Industry Players Ranking, 2024 VS 2025 VS 2026 Table 25. Global Key Players of Lipid Nanoparticle (LNP) CDMO Service, Headquarters and Area Served Table 26. Global Lipid Nanoparticle (LNP) CDMO Service Players, Product Type & Application Table 27. Global Players Market Concentration Ratio (CR5 and HHI) Table 28. Global Lipid Nanoparticle (LNP) CDMO Service by Players Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 29. Players Mergers & Acquisitions, Expansion Plans Table 30. North America Lipid Nanoparticle (LNP) CDMO Service Market Growth Rate by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 31. North America Lipid Nanoparticle (LNP) CDMO Service Market Size by Country (2021-2026) & (US$ Million) Table 32. North America Lipid Nanoparticle (LNP) CDMO Service Market Size by Country (2027-2032) & (US$ Million) Table 33. Europe Lipid Nanoparticle (LNP) CDMO Service Market Growth Rate by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 34. Europe Lipid Nanoparticle (LNP) CDMO Service Market Size by Country (2021-2026) & (US$ Million) Table 35. Europe Lipid Nanoparticle (LNP) CDMO Service Market Size by Country (2027-2032) & (US$ Million) Table 36. Asia Pacific Lipid Nanoparticle (LNP) CDMO Service Market Growth Rate by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 37. Asia Pacific Lipid Nanoparticle (LNP) CDMO Service Market Size by Region (2021-2026) & (US$ Million) Table 38. Asia Pacific Lipid Nanoparticle (LNP) CDMO Service Market Size by Country (2027-2032) & (US$ Million) Table 39. South America Lipid Nanoparticle (LNP) CDMO Service Market Growth Rate by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 40. South America Lipid Nanoparticle (LNP) CDMO Service Market Size by Country (2021-2026) & (US$ Million) Table 41. South America Lipid Nanoparticle (LNP) CDMO Service Market Size by Country (2027-2032) & (US$ Million) Table 42. Middle East & Africa Lipid Nanoparticle (LNP) CDMO Service Market Growth Rate by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 43. Middle East & Africa Lipid Nanoparticle (LNP) CDMO Service Market Size by Country (2021-2026) & (US$ Million) Table 44. Middle East & Africa Lipid Nanoparticle (LNP) CDMO Service Market Size by Country (2027-2032) & (US$ Million) Table 45. Evonik Company Information Table 46. Evonik Business Overview Table 47. Evonik Revenue in Lipid Nanoparticle (LNP) CDMO Service Business (2021-2026) & (US$ Million) Table 48. Evonik Lipid Nanoparticle (LNP) CDMO Service Product Portfolio Table 49. Evonik Recent Developments Table 50. Helix Biotech Company Information Table 51. Helix Biotech Business Overview Table 52. Helix Biotech Revenue in Lipid Nanoparticle (LNP) CDMO Service Business (2021-2026) & (US$ Million) Table 53. Helix Biotech Lipid Nanoparticle (LNP) CDMO Service Product Portfolio Table 54. Helix Biotech Recent Developments Table 55. FUJIFILM Holdings Company Information Table 56. FUJIFILM Holdings Business Overview Table 57. FUJIFILM Holdings Revenue in Lipid Nanoparticle (LNP) CDMO Service Business (2021-2026) & (US$ Million) Table 58. FUJIFILM Holdings Lipid Nanoparticle (LNP) CDMO Service Product Portfolio Table 59. FUJIFILM Holdings Recent Developments Table 60. Merck Company Information Table 61. Merck Business Overview Table 62. Merck Revenue in Lipid Nanoparticle (LNP) CDMO Service Business (2021-2026) & (US$ Million) Table 63. Merck Lipid Nanoparticle (LNP) CDMO Service Product Portfolio Table 64. Merck Recent Developments Table 65. Ascendia Pharmaceuticals Company Information Table 66. Ascendia Pharmaceuticals Business Overview Table 67. Ascendia Pharmaceuticals Revenue in Lipid Nanoparticle (LNP) CDMO Service Business (2021-2026) & (US$ Million) Table 68. Ascendia Pharmaceuticals Lipid Nanoparticle (LNP) CDMO Service Product Portfolio Table 69. Ascendia Pharmaceuticals Recent Developments Table 70. Catalent Company Information Table 71. Catalent Business Overview Table 72. Catalent Revenue in Lipid Nanoparticle (LNP) CDMO Service Business (2021-2026) & (US$ Million) Table 73. Catalent Lipid Nanoparticle (LNP) CDMO Service Product Portfolio Table 74. Catalent Recent Developments Table 75. Polymun Scientific Company Information Table 76. Polymun Scientific Business Overview Table 77. Polymun Scientific Revenue in Lipid Nanoparticle (LNP) CDMO Service Business (2021-2026) & (US$ Million) Table 78. Polymun Scientific Lipid Nanoparticle (LNP) CDMO Service Product Portfolio Table 79. Polymun Scientific Recent Developments Table 80. Genevant Sciences Company Information Table 81. Genevant Sciences Business Overview Table 82. Genevant Sciences Revenue in Lipid Nanoparticle (LNP) CDMO Service Business (2021-2026) & (US$ Million) Table 83. Genevant Sciences Lipid Nanoparticle (LNP) CDMO Service Product Portfolio Table 84. Genevant Sciences Recent Developments Table 85. Cytiva Company Information Table 86. Cytiva Business Overview Table 87. Cytiva Revenue in Lipid Nanoparticle (LNP) CDMO Service Business (2021-2026) & (US$ Million) Table 88. Cytiva Lipid Nanoparticle (LNP) CDMO Service Product Portfolio Table 89. Cytiva Recent Developments Table 90. Croda International Company Information Table 91. Croda International Business Overview Table 92. Croda International Revenue in Lipid Nanoparticle (LNP) CDMO Service Business (2021-2026) & (US$ Million) Table 93. Croda International Lipid Nanoparticle (LNP) CDMO Service Product Portfolio Table 94. Croda International Recent Developments Table 95. Nippon Fine Chemical Company Information Table 96. Nippon Fine Chemical Business Overview Table 97. Nippon Fine Chemical Revenue in Lipid Nanoparticle (LNP) CDMO Service Business (2021-2026) & (US$ Million) Table 98. Nippon Fine Chemical Lipid Nanoparticle (LNP) CDMO Service Product Portfolio Table 99. Nippon Fine Chemical Recent Developments Table 100. Patheon Company Information Table 101. Patheon Business Overview Table 102. Patheon Revenue in Lipid Nanoparticle (LNP) CDMO Service Business (2021-2026) & (US$ Million) Table 103. Patheon Lipid Nanoparticle (LNP) CDMO Service Product Portfolio Table 104. Patheon Recent Developments Table 105. Biomay Company Information Table 106. Biomay Business Overview Table 107. Biomay Revenue in Lipid Nanoparticle (LNP) CDMO Service Business (2021-2026) & (US$ Million) Table 108. Biomay Lipid Nanoparticle (LNP) CDMO Service Product Portfolio Table 109. Biomay Recent Developments Table 110. Pace Analytical Company Information Table 111. Pace Analytical Business Overview Table 112. Pace Analytical Revenue in Lipid Nanoparticle (LNP) CDMO Service Business (2021-2026) & (US$ Million) Table 113. Pace Analytical Lipid Nanoparticle (LNP) CDMO Service Product Portfolio Table 114. Pace Analytical Recent Developments Table 115. CordenPharma Company Information Table 116. CordenPharma Business Overview Table 117. CordenPharma Revenue in Lipid Nanoparticle (LNP) CDMO Service Business (2021-2026) & (US$ Million) Table 118. CordenPharma Lipid Nanoparticle (LNP) CDMO Service Product Portfolio Table 119. CordenPharma Recent Developments Table 120. Vernal Biosciences Company Information Table 121. Vernal Biosciences Business Overview Table 122. Vernal Biosciences Revenue in Lipid Nanoparticle (LNP) CDMO Service Business (2021-2026) & (US$ Million) Table 123. Vernal Biosciences Lipid Nanoparticle (LNP) CDMO Service Product Portfolio Table 124. Vernal Biosciences Recent Developments Table 125. Lonza Company Information Table 126. Lonza Business Overview Table 127. Lonza Revenue in Lipid Nanoparticle (LNP) CDMO Service Business (2021-2026) & (US$ Million) Table 128. Lonza Lipid Nanoparticle (LNP) CDMO Service Product Portfolio Table 129. Lonza Recent Developments Table 130. Acuitas Therapeutics Company Information Table 131. Acuitas Therapeutics Business Overview Table 132. Acuitas Therapeutics Revenue in Lipid Nanoparticle (LNP) CDMO Service Business (2021-2026) & (US$ Million) Table 133. Acuitas Therapeutics Lipid Nanoparticle (LNP) CDMO Service Product Portfolio Table 134. Acuitas Therapeutics Recent Developments Table 135. Creative Biolabs Company Information Table 136. Creative Biolabs Business Overview Table 137. Creative Biolabs Revenue in Lipid Nanoparticle (LNP) CDMO Service Business (2021-2026) & (US$ Million) Table 138. Creative Biolabs Lipid Nanoparticle (LNP) CDMO Service Product Portfolio Table 139. Creative Biolabs Recent Developments Table 140. WuXi STA Company Information Table 141. WuXi STA Business Overview Table 142. WuXi STA Revenue in Lipid Nanoparticle (LNP) CDMO Service Business (2021-2026) & (US$ Million) Table 143. WuXi STA Lipid Nanoparticle (LNP) CDMO Service Product Portfolio Table 144. WuXi STA Recent Developments Table 145. GenScript Company Information Table 146. GenScript Business Overview Table 147. GenScript Revenue in Lipid Nanoparticle (LNP) CDMO Service Business (2021-2026) & (US$ Million) Table 148. GenScript Lipid Nanoparticle (LNP) CDMO Service Product Portfolio Table 149. GenScript Recent Developments Table 150. MicroNano Biologics Company Information Table 151. MicroNano Biologics Business Overview Table 152. MicroNano Biologics Revenue in Lipid Nanoparticle (LNP) CDMO Service Business (2021-2026) & (US$ Million) Table 153. MicroNano Biologics Lipid Nanoparticle (LNP) CDMO Service Product Portfolio Table 154. MicroNano Biologics Recent Developments Table 155. Authors List of This Report List of Figures Figure 1. Research Methodology Figure 2. Research Process Figure 3. Key Executives Interviewed Figure 4. Lipid Nanoparticle (LNP) CDMO Service Product Image Figure 5. Global Lipid Nanoparticle (LNP) CDMO Service Market Size Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 6. Global Lipid Nanoparticle (LNP) CDMO Service Market Share by Type: 2025 VS 2032 Figure 7. Formulation Development Product Figure 8. cGMP Manufacturing Product Figure 9. Others Product Figure 10. Global Lipid Nanoparticle (LNP) CDMO Service Market Size by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 11. Global Lipid Nanoparticle (LNP) CDMO Service Market Share by Application: 2025 VS 2032 Figure 12. Vaccine Development Product Figure 13. Gene Therapy Product Figure 14. Drug Delivery Product Figure 15. Others Product Figure 16. Global Lipid Nanoparticle (LNP) CDMO Service Market Size (US$ Million), Year-over-Year: 2021-2032 Figure 17. Global Lipid Nanoparticle (LNP) CDMO Service Market Size, (US$ Million), 2021 VS 2025 VS 2032 Figure 18. Global Lipid Nanoparticle (LNP) CDMO Service Market Share by Region: 2025 VS 2032 Figure 19. Global Lipid Nanoparticle (LNP) CDMO Service Market Share by Players in 2025 Figure 20. Global Lipid Nanoparticle (LNP) CDMO Service Manufacturers Established Date Figure 21. Global Top 5 and 10 Lipid Nanoparticle (LNP) CDMO Service Players Market Share by Revenue in 2025 Figure 22. Players Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 23. North America Lipid Nanoparticle (LNP) CDMO Service Market Size YoY Growth (2021-2032) & (US$ Million) Figure 24. North America Lipid Nanoparticle (LNP) CDMO Service Market Share by Country (2021-2032) Figure 25. United States Lipid Nanoparticle (LNP) CDMO Service Market Size YoY Growth (2021-2032) & (US$ Million) Figure 26. Canada Lipid Nanoparticle (LNP) CDMO Service Market Size YoY Growth (2021-2032) & (US$ Million) Figure 27. Mexico Lipid Nanoparticle (LNP) CDMO Service Market Share by Country (2021-2032) Figure 28. Europe Lipid Nanoparticle (LNP) CDMO Service Market Size YoY Growth (2021-2032) & (US$ Million) Figure 29. Europe Lipid Nanoparticle (LNP) CDMO Service Market Share by Country (2021-2032) Figure 30. Germany Lipid Nanoparticle (LNP) CDMO Service Market Size YoY Growth (2021-2032) & (US$ Million) Figure 31. France Lipid Nanoparticle (LNP) CDMO Service Market Size YoY Growth (2021-2032) & (US$ Million) Figure 32. U.K. Lipid Nanoparticle (LNP) CDMO Service Market Size YoY Growth (2021-2032) & (US$ Million) Figure 33. Italy Lipid Nanoparticle (LNP) CDMO Service Market Size YoY Growth (2021-2032) & (US$ Million) Figure 34. Spain Lipid Nanoparticle (LNP) CDMO Service Market Size YoY Growth (2021-2032) & (US$ Million) Figure 35. Russia Lipid Nanoparticle (LNP) CDMO Service Market Size YoY Growth (2021-2032) & (US$ Million) Figure 36. Netherlands Lipid Nanoparticle (LNP) CDMO Service Market Size YoY Growth (2021-2032) & (US$ Million) Figure 37. Nordic Countries Lipid Nanoparticle (LNP) CDMO Service Market Size YoY Growth (2021-2032) & (US$ Million) Figure 38. Asia-Pacific Lipid Nanoparticle (LNP) CDMO Service Market Size YoY Growth (2021-2032) & (US$ Million) Figure 39. Asia-Pacific Lipid Nanoparticle (LNP) CDMO Service Market Share by Country (2021-2032) Figure 40. China Lipid Nanoparticle (LNP) CDMO Service Market Size YoY Growth (2021-2032) & (US$ Million) Figure 41. Japan Lipid Nanoparticle (LNP) CDMO Service Market Size YoY Growth (2021-2032) & (US$ Million) Figure 42. South Korea Lipid Nanoparticle (LNP) CDMO Service Market Size YoY Growth (2021-2032) & (US$ Million) Figure 43. India Lipid Nanoparticle (LNP) CDMO Service Market Size YoY Growth (2021-2032) & (US$ Million) Figure 44. India Lipid Nanoparticle (LNP) CDMO Service Market Share by Country (2021-2032) Figure 45. Australia Lipid Nanoparticle (LNP) CDMO Service Market Size YoY Growth (2021-2032) & (US$ Million) Figure 46. China Taiwan Lipid Nanoparticle (LNP) CDMO Service Market Size YoY Growth (2021-2032) & (US$ Million) Figure 47. Southeast Asia Lipid Nanoparticle (LNP) CDMO Service Market Size YoY Growth (2021-2032) & (US$ Million) Figure 48. South America Lipid Nanoparticle (LNP) CDMO Service Market Size YoY Growth (2021-2032) & (US$ Million) Figure 49. South America Lipid Nanoparticle (LNP) CDMO Service Market Share by Country (2021-2032) Figure 50. Brazil Lipid Nanoparticle (LNP) CDMO Service Market Size YoY Growth (2021-2032) & (US$ Million) Figure 51. Argentina Lipid Nanoparticle (LNP) CDMO Service Market Size YoY Growth (2021-2032) & (US$ Million) Figure 52. Chile Lipid Nanoparticle (LNP) CDMO Service Market Size YoY Growth (2021-2032) & (US$ Million) Figure 53. Colombia Lipid Nanoparticle (LNP) CDMO Service Market Size YoY Growth (2021-2032) & (US$ Million) Figure 54. Peru Lipid Nanoparticle (LNP) CDMO Service Market Size YoY Growth (2021-2032) & (US$ Million) Figure 55. Evonik Revenue Growth Rate in Lipid Nanoparticle (LNP) CDMO Service Business (2021-2026) Figure 56. Helix Biotech Revenue Growth Rate in Lipid Nanoparticle (LNP) CDMO Service Business (2021-2026) Figure 57. FUJIFILM Holdings Revenue Growth Rate in Lipid Nanoparticle (LNP) CDMO Service Business (2021-2026) Figure 58. Merck Revenue Growth Rate in Lipid Nanoparticle (LNP) CDMO Service Business (2021-2026) Figure 59. Ascendia Pharmaceuticals Revenue Growth Rate in Lipid Nanoparticle (LNP) CDMO Service Business (2021-2026) Figure 60. Catalent Revenue Growth Rate in Lipid Nanoparticle (LNP) CDMO Service Business (2021-2026) Figure 61. Polymun Scientific Revenue Growth Rate in Lipid Nanoparticle (LNP) CDMO Service Business (2021-2026) Figure 62. Genevant Sciences Revenue Growth Rate in Lipid Nanoparticle (LNP) CDMO Service Business (2021-2026) Figure 63. Cytiva Revenue Growth Rate in Lipid Nanoparticle (LNP) CDMO Service Business (2021-2026) Figure 64. Croda International Revenue Growth Rate in Lipid Nanoparticle (LNP) CDMO Service Business (2021-2026) Figure 65. Nippon Fine Chemical Revenue Growth Rate in Lipid Nanoparticle (LNP) CDMO Service Business (2021-2026) Figure 66. Patheon Revenue Growth Rate in Lipid Nanoparticle (LNP) CDMO Service Business (2021-2026) Figure 67. Biomay Revenue Growth Rate in Lipid Nanoparticle (LNP) CDMO Service Business (2021-2026) Figure 68. Pace Analytical Revenue Growth Rate in Lipid Nanoparticle (LNP) CDMO Service Business (2021-2026) Figure 69. CordenPharma Revenue Growth Rate in Lipid Nanoparticle (LNP) CDMO Service Business (2021-2026) Figure 70. Vernal Biosciences Revenue Growth Rate in Lipid Nanoparticle (LNP) CDMO Service Business (2021-2026) Figure 71. Lonza Revenue Growth Rate in Lipid Nanoparticle (LNP) CDMO Service Business (2021-2026) Figure 72. Acuitas Therapeutics Revenue Growth Rate in Lipid Nanoparticle (LNP) CDMO Service Business (2021-2026) Figure 73. Creative Biolabs Revenue Growth Rate in Lipid Nanoparticle (LNP) CDMO Service Business (2021-2026) Figure 74. WuXi STA Revenue Growth Rate in Lipid Nanoparticle (LNP) CDMO Service Business (2021-2026) Figure 75. GenScript Revenue Growth Rate in Lipid Nanoparticle (LNP) CDMO Service Business (2021-2026) Figure 76. MicroNano Biologics Revenue Growth Rate in Lipid Nanoparticle (LNP) CDMO Service Business (2021-2026)

Scope & coverage.

Types
  • Formulation Development
  • cGMP Manufacturing
  • Others
Applications
  • Vaccine Development
  • Gene Therapy
  • Drug Delivery
  • Others
Companies covered
  • Evonik
  • Helix Biotech
  • FUJIFILM Holdings
  • Merck
  • Ascendia Pharmaceuticals
  • Catalent
  • Polymun Scientific
  • Genevant Sciences
  • Cytiva
  • Croda International
  • Nippon Fine Chemical
  • Patheon
  • Biomay
  • Pace Analytical
  • CordenPharma
  • Vernal Biosciences
  • Lonza
  • Acuitas Therapeutics
  • Creative Biolabs
  • WuXi STA
  • GenScript
  • MicroNano Biologics

Inside the report.

1 Preface
  1. 1.1 Scope of Report
  2. 1.2 Reasons for Doing This Study
  3. 1.3 Research Methodology
  4. 1.4 Research Process
  5. 1.5 Data Source
  6. 1.5.1 Secondary Sources
  7. 1.5.2 Primary Sources
2 Market Overview
  1. 2.1 Product Definition
  2. 2.2 Lipid Nanoparticle (LNP) CDMO Service by Type
  3. 2.2.1 Market Value Comparison by Type (2021 VS 2025 VS 2032)
  4. 2.2.2 Formulation Development
  5. 2.2.3 cGMP Manufacturing
  6. 2.2.4 Others
  7. 2.3 Lipid Nanoparticle (LNP) CDMO Service by Application
  8. 2.3.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
  9. 2.3.2 Vaccine Development
  10. 2.3.3 Gene Therapy
  11. 2.3.4 Drug Delivery
  12. 2.3.5 Others
  13. 2.4 Assumptions and Limitations
3 Lipid Nanoparticle (LNP) CDMO Service Breakdown Data by Type
  1. 3.1 Global Lipid Nanoparticle (LNP) CDMO Service Historic Market Size by Type (2021-2026)
  2. 3.2 Global Lipid Nanoparticle (LNP) CDMO Service Forecasted Market Size by Type (2027-2032)
4 Lipid Nanoparticle (LNP) CDMO Service Breakdown Data by Application
  1. 4.1 Global Lipid Nanoparticle (LNP) CDMO Service Historic Market Size by Application (2021-2026)
  2. 4.2 Global Lipid Nanoparticle (LNP) CDMO Service Forecasted Market Size by Application (2027-2032)
5 Global Growth Trends
  1. 5.1 Global Lipid Nanoparticle (LNP) CDMO Service Market Perspective (2021-2032)
  2. 5.2 Global Lipid Nanoparticle (LNP) CDMO Service Growth Trends by Region
  3. 5.2.1 Global Lipid Nanoparticle (LNP) CDMO Service Market Size by Region: 2021 VS 2025 VS 2032
  4. 5.2.2 Lipid Nanoparticle (LNP) CDMO Service Historic Market Size by Region (2021-2026)
  5. 5.2.3 Lipid Nanoparticle (LNP) CDMO Service Forecasted Market Size by Region (2027-2032)
  6. 5.3 Lipid Nanoparticle (LNP) CDMO Service Market Dynamics
  7. 5.3.1 Lipid Nanoparticle (LNP) CDMO Service Industry Trends
  8. 5.3.2 Lipid Nanoparticle (LNP) CDMO Service Market Drivers
  9. 5.3.3 Lipid Nanoparticle (LNP) CDMO Service Market Challenges
  10. 5.3.4 Lipid Nanoparticle (LNP) CDMO Service Market Restraints
6 Market Competitive Landscape by Players
  1. 6.1 Global Top Lipid Nanoparticle (LNP) CDMO Service Players by Revenue
  2. 6.1.1 Global Top Lipid Nanoparticle (LNP) CDMO Service Players by Revenue (2021-2026)
  3. 6.1.2 Global Lipid Nanoparticle (LNP) CDMO Service Revenue Market Share by Players (2021-2026)
  4. 6.2 Global Lipid Nanoparticle (LNP) CDMO Service Industry Players Ranking, 2023 VS 2024 VS 2025
  5. 6.3 Global Key Players of Lipid Nanoparticle (LNP) CDMO Service Head Office and Area Served
  6. 6.4 Global Lipid Nanoparticle (LNP) CDMO Service Players, Product Type & Application
  7. 6.5 Global Lipid Nanoparticle (LNP) CDMO Service Manufacturers Established Date
  8. 6.6 Global Lipid Nanoparticle (LNP) CDMO Service Market CR5 and HHI
  9. 6.7 Global Players Mergers & Acquisition
7 North America
  1. 7.1 North America Lipid Nanoparticle (LNP) CDMO Service Market Size (2021-2032)
  2. 7.2 North America Lipid Nanoparticle (LNP) CDMO Service Market Growth Rate by Country: 2021 VS 2025 VS 2032
  3. 7.3 North America Lipid Nanoparticle (LNP) CDMO Service Market Size by Country (2021-2026)
  4. 7.4 North America Lipid Nanoparticle (LNP) CDMO Service Market Size by Country (2027-2032)
  5. 7.5 United States
  6. 7.5 United States
  7. 7.6 Canada
  8. 7.7 Mexico
8 Europe
  1. 8.1 Europe Lipid Nanoparticle (LNP) CDMO Service Market Size (2021-2032)
  2. 8.2 Europe Lipid Nanoparticle (LNP) CDMO Service Market Growth Rate by Country: 2021 VS 2025 VS 2032
  3. 8.3 Europe Lipid Nanoparticle (LNP) CDMO Service Market Size by Country (2021-2026)
  4. 8.4 Europe Lipid Nanoparticle (LNP) CDMO Service Market Size by Country (2027-2032)
  5. 8.5 Germany
  6. 8.6 France
  7. 8.7 U.K.
  8. 8.8 Italy
  9. 8.9 Spain
  10. 8.10 Russia
  11. 8.11 Netherlands
  12. 8.12 Nordic Countries
9 Asia-Pacific
  1. 9.1 Asia-Pacific Lipid Nanoparticle (LNP) CDMO Service Market Size (2021-2032)
  2. 9.2 Asia-Pacific Lipid Nanoparticle (LNP) CDMO Service Market Growth Rate by Country: 2021 VS 2025 VS 2032
  3. 9.3 Asia-Pacific Lipid Nanoparticle (LNP) CDMO Service Market Size by Country (2021-2026)
  4. 9.4 Asia-Pacific Lipid Nanoparticle (LNP) CDMO Service Market Size by Country (2027-2032)
  5. 9.5 China
  6. 9.6 Japan
  7. 9.7 South Korea
  8. 9.8 India
  9. 9.9 Australia
  10. 9.10 China Taiwan
  11. 9.11 Southeast Asia
10 South America
  1. 10.1 South America Lipid Nanoparticle (LNP) CDMO Service Market Size (2021-2032)
  2. 10.2 South America Lipid Nanoparticle (LNP) CDMO Service Market Growth Rate by Country: 2021 VS 2025 VS 2032
  3. 10.3 South America Lipid Nanoparticle (LNP) CDMO Service Market Size by Country (2021-2026)
  4. 10.4 South America Lipid Nanoparticle (LNP) CDMO Service Market Size by Country (2027-2032)
  5. 10.5 Brazil
  6. 10.6 Argentina
  7. 10.7 Chile
  8. 10.8 Colombia
  9. 10.9 Peru
11 Middle East & Africa
  1. 11.1 Middle East & Africa Lipid Nanoparticle (LNP) CDMO Service Market Size (2021-2032)
  2. 11.2 Middle East & Africa Lipid Nanoparticle (LNP) CDMO Service Market Growth Rate by Country: 2021 VS 2025 VS 2032
  3. 11.3 Middle East & Africa Lipid Nanoparticle (LNP) CDMO Service Market Size by Country (2021-2026)
  4. 11.4 Middle East & Africa Lipid Nanoparticle (LNP) CDMO Service Market Size by Country (2027-2032)
  5. 11.5 Saudi Arabia
  6. 11.6 Israel
  7. 11.7 United Arab Emirates
  8. 11.8 Turkey
  9. 11.9 Iran
  10. 11.10 Egypt
12 Players Profiled
  1. 12.1 Evonik
  2. 12.1.1 Evonik Company Information
  3. 12.1.2 Evonik Business Overview
  4. 12.1.3 Evonik Revenue in Lipid Nanoparticle (LNP) CDMO Service Business (2021-2026)
  5. 12.1.4 Evonik Lipid Nanoparticle (LNP) CDMO Service Product Portfolio
  6. 12.1.5 Evonik Recent Developments
  7. 12.2 Helix Biotech
  8. 12.2.1 Helix Biotech Company Information
  9. 12.2.2 Helix Biotech Business Overview
  10. 12.2.3 Helix Biotech Revenue in Lipid Nanoparticle (LNP) CDMO Service Business (2021-2026)
  11. 12.2.4 Helix Biotech Lipid Nanoparticle (LNP) CDMO Service Product Portfolio
  12. 12.2.5 Helix Biotech Recent Developments
  13. 12.3 FUJIFILM Holdings
  14. 12.3.1 FUJIFILM Holdings Company Information
  15. 12.3.2 FUJIFILM Holdings Business Overview
  16. 12.3.3 FUJIFILM Holdings Revenue in Lipid Nanoparticle (LNP) CDMO Service Business (2021-2026)
  17. 12.3.4 FUJIFILM Holdings Lipid Nanoparticle (LNP) CDMO Service Product Portfolio
  18. 12.3.5 FUJIFILM Holdings Recent Developments
  19. 12.4 Merck
  20. 12.4.1 Merck Company Information
  21. 12.4.2 Merck Business Overview
  22. 12.4.3 Merck Revenue in Lipid Nanoparticle (LNP) CDMO Service Business (2021-2026)
  23. 12.4.4 Merck Lipid Nanoparticle (LNP) CDMO Service Product Portfolio
  24. 12.4.5 Merck Recent Developments
  25. 12.5 Ascendia Pharmaceuticals
  26. 12.5.1 Ascendia Pharmaceuticals Company Information
  27. 12.5.2 Ascendia Pharmaceuticals Business Overview
  28. 12.5.3 Ascendia Pharmaceuticals Revenue in Lipid Nanoparticle (LNP) CDMO Service Business (2021-2026)
  29. 12.5.4 Ascendia Pharmaceuticals Lipid Nanoparticle (LNP) CDMO Service Product Portfolio
  30. 12.5.5 Ascendia Pharmaceuticals Recent Developments
  31. 12.6 Catalent
  32. 12.6.1 Catalent Company Information
  33. 12.6.2 Catalent Business Overview
  34. 12.6.3 Catalent Revenue in Lipid Nanoparticle (LNP) CDMO Service Business (2021-2026)
  35. 12.6.4 Catalent Lipid Nanoparticle (LNP) CDMO Service Product Portfolio
  36. 12.6.5 Catalent Recent Developments
  37. 12.7 Polymun Scientific
  38. 12.7.1 Polymun Scientific Company Information
  39. 12.7.2 Polymun Scientific Business Overview
  40. 12.7.3 Polymun Scientific Revenue in Lipid Nanoparticle (LNP) CDMO Service Business (2021-2026)
  41. 12.7.4 Polymun Scientific Lipid Nanoparticle (LNP) CDMO Service Product Portfolio
  42. 12.7.5 Polymun Scientific Recent Developments
  43. 12.8 Genevant Sciences
  44. 12.8.1 Genevant Sciences Company Information
  45. 12.8.2 Genevant Sciences Business Overview
  46. 12.8.3 Genevant Sciences Revenue in Lipid Nanoparticle (LNP) CDMO Service Business (2021-2026)
  47. 12.8.4 Genevant Sciences Lipid Nanoparticle (LNP) CDMO Service Product Portfolio
  48. 12.8.5 Genevant Sciences Recent Developments
  49. 12.9 Cytiva
  50. 12.9.1 Cytiva Company Information
  51. 12.9.2 Cytiva Business Overview
  52. 12.9.3 Cytiva Revenue in Lipid Nanoparticle (LNP) CDMO Service Business (2021-2026)
  53. 12.9.4 Cytiva Lipid Nanoparticle (LNP) CDMO Service Product Portfolio
  54. 12.9.5 Cytiva Recent Developments
  55. 12.10 Croda International
  56. 12.10.1 Croda International Company Information
  57. 12.10.2 Croda International Business Overview
  58. 12.10.3 Croda International Revenue in Lipid Nanoparticle (LNP) CDMO Service Business (2021-2026)
  59. 12.10.4 Croda International Lipid Nanoparticle (LNP) CDMO Service Product Portfolio
  60. 12.10.5 Croda International Recent Developments
  61. 12.11 Nippon Fine Chemical
  62. 12.11.1 Nippon Fine Chemical Company Information
  63. 12.11.2 Nippon Fine Chemical Business Overview
  64. 12.11.3 Nippon Fine Chemical Revenue in Lipid Nanoparticle (LNP) CDMO Service Business (2021-2026)
  65. 12.11.4 Nippon Fine Chemical Lipid Nanoparticle (LNP) CDMO Service Product Portfolio
  66. 12.11.5 Nippon Fine Chemical Recent Developments
  67. 12.12 Patheon
  68. 12.12.1 Patheon Company Information
  69. 12.12.2 Patheon Business Overview
  70. 12.12.3 Patheon Revenue in Lipid Nanoparticle (LNP) CDMO Service Business (2021-2026)
  71. 12.12.4 Patheon Lipid Nanoparticle (LNP) CDMO Service Product Portfolio
  72. 12.12.5 Patheon Recent Developments
  73. 12.13 Biomay
  74. 12.13.1 Biomay Company Information
  75. 12.13.2 Biomay Business Overview
  76. 12.13.3 Biomay Revenue in Lipid Nanoparticle (LNP) CDMO Service Business (2021-2026)
  77. 12.13.4 Biomay Lipid Nanoparticle (LNP) CDMO Service Product Portfolio
  78. 12.13.5 Biomay Recent Developments
  79. 12.14 Pace Analytical
  80. 12.14.1 Pace Analytical Company Information
  81. 12.14.2 Pace Analytical Business Overview
  82. 12.14.3 Pace Analytical Revenue in Lipid Nanoparticle (LNP) CDMO Service Business (2021-2026)
  83. 12.14.4 Pace Analytical Lipid Nanoparticle (LNP) CDMO Service Product Portfolio
  84. 12.14.5 Pace Analytical Recent Developments
  85. 12.15 CordenPharma
  86. 12.15.1 CordenPharma Company Information
  87. 12.15.2 CordenPharma Business Overview
  88. 12.15.3 CordenPharma Revenue in Lipid Nanoparticle (LNP) CDMO Service Business (2021-2026)
  89. 12.15.4 CordenPharma Lipid Nanoparticle (LNP) CDMO Service Product Portfolio
  90. 12.15.5 CordenPharma Recent Developments
  91. 12.16 Vernal Biosciences
  92. 12.16.1 Vernal Biosciences Company Information
  93. 12.16.2 Vernal Biosciences Business Overview
  94. 12.16.3 Vernal Biosciences Revenue in Lipid Nanoparticle (LNP) CDMO Service Business (2021-2026)
  95. 12.16.4 Vernal Biosciences Lipid Nanoparticle (LNP) CDMO Service Product Portfolio
  96. 12.16.5 Vernal Biosciences Recent Developments
  97. 12.17 Lonza
  98. 12.17.1 Lonza Company Information
  99. 12.17.2 Lonza Business Overview
  100. 12.17.3 Lonza Revenue in Lipid Nanoparticle (LNP) CDMO Service Business (2021-2026)
  101. 12.17.4 Lonza Lipid Nanoparticle (LNP) CDMO Service Product Portfolio
  102. 12.17.5 Lonza Recent Developments
  103. 12.18 Acuitas Therapeutics
  104. 12.18.1 Acuitas Therapeutics Company Information
  105. 12.18.2 Acuitas Therapeutics Business Overview
  106. 12.18.3 Acuitas Therapeutics Revenue in Lipid Nanoparticle (LNP) CDMO Service Business (2021-2026)
  107. 12.18.4 Acuitas Therapeutics Lipid Nanoparticle (LNP) CDMO Service Product Portfolio
  108. 12.18.5 Acuitas Therapeutics Recent Developments
  109. 12.19 Creative Biolabs
  110. 12.19.1 Creative Biolabs Company Information
  111. 12.19.2 Creative Biolabs Business Overview
  112. 12.19.3 Creative Biolabs Revenue in Lipid Nanoparticle (LNP) CDMO Service Business (2021-2026)
  113. 12.19.4 Creative Biolabs Lipid Nanoparticle (LNP) CDMO Service Product Portfolio
  114. 12.19.5 Creative Biolabs Recent Developments
  115. 12.20 WuXi STA
  116. 12.20.1 WuXi STA Company Information
  117. 12.20.2 WuXi STA Business Overview
  118. 12.20.3 WuXi STA Revenue in Lipid Nanoparticle (LNP) CDMO Service Business (2021-2026)
  119. 12.20.4 WuXi STA Lipid Nanoparticle (LNP) CDMO Service Product Portfolio
  120. 12.20.5 WuXi STA Recent Developments
  121. 12.21 GenScript
  122. 12.21.1 GenScript Company Information
  123. 12.21.2 GenScript Business Overview
  124. 12.21.3 GenScript Revenue in Lipid Nanoparticle (LNP) CDMO Service Business (2021-2026)
  125. 12.21.4 GenScript Lipid Nanoparticle (LNP) CDMO Service Product Portfolio
  126. 12.21.5 GenScript Recent Developments
  127. 12.22 MicroNano Biologics
  128. 12.22.1 MicroNano Biologics Company Information
  129. 12.22.2 MicroNano Biologics Business Overview
  130. 12.22.3 MicroNano Biologics Revenue in Lipid Nanoparticle (LNP) CDMO Service Business (2021-2026)
  131. 12.22.4 MicroNano Biologics Lipid Nanoparticle (LNP) CDMO Service Product Portfolio
  132. 12.22.5 MicroNano Biologics Recent Developments
13 Report Conclusion
    14 Disclaimer

      GET THE RESEARCH

      Choose your license.

      Choose who needs access.
      All options are for this report and research series.

      Compare access permissions.

      Single User License
      One named user. Individual access.
      Multi User License
      Up to 5 users in the same department.
      Enterprise License
      Organization-wide access within the agreed license.

      Access applies to the purchased edition. Later editions are separate purchases.

      License options
      $2,950USD
      Buy now

      PDF by email within 3–5 working days after payment confirmation.

      Talk to an analyst
      APO Research
      Talk to an analyst